Hymenoptera venom immunotherapy (Q37842330)

24 August 2017

1 reference

title

Hymenoptera venom immunotherapy (English)

1 reference

24 August 2017

0 references

0 references

1 reference

Beatrice M Bilò

1

1 reference

PubMed ID

21322761

24 August 2017

Floriano Bonifazi

series ordinal

2

1 reference

24 August 2017

1 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

3

1 reference

24 August 2017

2

1 reference

24 August 2017

229-246

1 reference

Diagnosis of Hymenoptera venom allergy

24 August 2017

1 reference

Epidemiology of insect-venom anaphylaxis

21 January 2018

1 reference

Stinging insect hypersensitivity: a practice parameter update

21 January 2018

1 reference

21 January 2018

Insect sting anaphylaxis

1 reference

The natural history and epidemiology of insect venom allergy: clinical implications

21 January 2018

1 reference

Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.

21 January 2018

1 reference

Allergic reactions to insect stings: results from a national survey of 10,000 junior high school children in Israel

21 January 2018

1 reference

Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy.

21 January 2018

1 reference

Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice

21 January 2018

1 reference

Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom

21 January 2018

1 reference

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

21 January 2018

1 reference

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

21 January 2018

1 reference

T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases

21 January 2018

1 reference

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.

21 January 2018

1 reference

Mechanisms of immunotherapy: IgG revisited

21 January 2018

1 reference

Mechanisms of allergen specific immunotherapy--T-cell tolerance and more

21 January 2018

1 reference

Changes in intracellular cyclic adenosine monophosphate levels in peripheral blood leukocytes during immunotherapy with vespid venom.

21 January 2018

1 reference

Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensiti

21 January 2018

1 reference

Characterization of the major allergens purified from the venom of the paper wasp Polistes gallicus.

21 January 2018

1 reference

Advances in hymenoptera venom immunotherapy

21 January 2018

1 reference

Diagnostic methods for insect sting allergy

21 January 2018

1 reference

Insect sting allergy with negative venom skin test responses

21 January 2018

1 reference

Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy.

21 January 2018

1 reference

Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.

21 January 2018

1 reference

Recombinant allergen-based IgE testing to distinguish bee and wasp allergy.

21 January 2018

1 reference

Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity.

21 January 2018

1 reference

Dialyzed venom skin tests for identifying yellow jacket-allergic patients not detected using standard venom.

21 January 2018

1 reference

Cellular in vitro assays in the diagnosis of Hymenoptera venom allergy.

21 January 2018

1 reference

Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results.

21 January 2018

1 reference

Diagnostic tests based on human basophils: potentials, pitfalls and perspectives.

21 January 2018

1 reference

Hymenoptera venom allergy

21 January 2018

1 reference

Practice of venom immunotherapy in the United Kingdom: a national audit and review of literature

21 January 2018

1 reference

Insect sting allergy and venom immunotherapy: a model and a mystery

21 January 2018

1 reference

Natural history of Hymenoptera venom sensitivity in adults

21 January 2018

1 reference

Natural history of Hymenoptera venom allergy in Eastern Spain.

21 January 2018

1 reference

Mastocytosis and Hymenoptera venom allergy

21 January 2018

1 reference

Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy

21 January 2018

1 reference

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

21 January 2018

1 reference

Stinging and biting insect allergy: an Australian experience.

21 January 2018

1 reference

Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis.

21 January 2018

1 reference

Venom immunotherapy reduces large local reactions to insect stings

21 January 2018

1 reference

Cardiovascular disease and anaphylaxis

21 January 2018

1 reference

Use of beta-blockers during immunotherapy for Hymenoptera venom allergy.

21 January 2018

1 reference

Risk of severe anaphylaxis for patients with Hymenoptera venom allergy: Are angiotensin-receptor blockers comparable to angiotensin-converting enzyme inhibitors?

21 January 2018

1 reference

21 January 2018

Venom hypersensitivity

1 reference

Selection of Hymenoptera venoms for immunotherapy on the basis of patient's IgE antibody cross-reactivity.

21 January 2018

1 reference

Safety and efficacy of immunotherapy with Polistes dominulus venom: results from a large Italian database.

21 January 2018

1 reference

Determination of IgE antibodies to Polistes dominulus, Vespula germanica and Vespa crabro in sera of patients allergic to vespids

21 January 2018

1 reference

21 January 2018

Allergy to bumblebees

1 reference

Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial.

21 January 2018

1 reference

Effectiveness of specific immunotherapy in the treatment of hymenoptera venom hypersensitivity: a meta-analysis

21 January 2018

1 reference

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

21 January 2018

1 reference

Mastocytosis and Hymenoptera allergy

21 January 2018

1 reference

Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis.

21 January 2018

1 reference

Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy

21 January 2018

1 reference

The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.

21 January 2018

1 reference

Purified vs. nonpurified venom immunotherapy

21 January 2018

1 reference

Bee venom allergy in beekeepers and their family members

21 January 2018

1 reference

Continuous immunotherapy for hymenoptera venom allergy using six month intervals.

21 January 2018

1 reference

Effectiveness of maintenance bee venom immunotherapy administered at 6-month intervals.

21 January 2018

1 reference

The Hymenoptera venom study. III: Safety of venom immunotherapy.

21 January 2018

1 reference

Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

High sensitivity of basophils predicts side-effects in venom immunotherapy.

21 January 2018

1 reference

Venom immunotherapy: adverse reactions and treatment failure

21 January 2018

1 reference

Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors.

21 January 2018

1 reference

Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.

21 January 2018

1 reference

ACE inhibitors and anaphylactoid reactions during venom immunotherapy

21 January 2018

1 reference

Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy.

21 January 2018

1 reference

Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy

21 January 2018

1 reference

Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy

21 January 2018

1 reference

Premedication with montelukast reduces local reactions of allergen immunotherapy.

21 January 2018

1 reference

High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis.

21 January 2018

1 reference

Sublingual immunotherapy for allergic respiratory diseases: an evaluation of meta-analyses

21 January 2018

1 reference

Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy.

21 January 2018

1 reference

The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts.

21 January 2018

1 reference

Discontinuing venom immunotherapy: outcome after five years.

21 January 2018

1 reference

Discontinuing venom immunotherapy: extended observations

21 January 2018

1 reference

Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations.

21 January 2018

1 reference

Basophil sensitivity in patients not responding to venom immunotherapy.

21 January 2018

1 reference

Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses

21 January 2018

1 reference

Discontinuing venom immunotherapy

21 January 2018

1 reference

Insect sting anoxic encephalopathy after stopping venom immunotherapy

21 January 2018

1 reference

Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients.

21 January 2018

1 reference

Survey of patients after discontinuing venom immunotherapy.

21 January 2018

1 reference

Long-term efficacy of venom immunotherapy.

21 January 2018

1 reference

Recombinant Hymenoptera venom allergens

21 January 2018

1 reference

Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3.

21 January 2018

1 reference

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom

21 January 2018

1 reference

Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice.

21 January 2018

1 reference

A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.

21 January 2018

1 reference

Prevention of allergy by a recombinant multi-allergen vaccine with reduced IgE binding and preserved T cell epitopes

21 January 2018

1 reference

Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial

21 January 2018

1 reference

Diagnosis and treatment of insect sensitivity.

21 January 2018

1 reference

Incidence and severity of anaphylactoid reactions to colloid volume substitutes

21 January 2018

1 reference

Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.10.88

1 reference

24 August 2017

1 reference

PubMed ID

21322761